
The Weekly Roundup: June 30-July 3
Key Takeaways
- Hair care products are being reformulated to support acne-prone skin, improving overall skin health.
- Teledermatology is enhancing healthcare access in underserved areas, addressing disparities.
In case you missed it, this week we had news about the FDA's RPD Designation of QRX003 for Netherton Syndrome, Galderma's 2 new clinical trials of nemolizumab, Allergan Aesthetics' sPMA for SKINVIVE by Juvéderm, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our
Iris Rubin, MD, reveals how her brand SEEN transforms hair products to combat acne, promoting clearer skin through innovative, skin-friendly formulations.
UC Berkeley’s Broc Vargo shares how growing up in tanning salons inspired his passion for dermatology, sun safety, and public health advocacy.
Iris Rubin, MD, highlights SEEN's science-backed hair care, designed for acne-prone skin, improving scalp health and reducing irritation.
Discover Hershel Dobkin's unique blend of humor and dermatology, offering insights that combat clinical burnout and bring joy to medical practice.
Renata Block, DMSc, MMS, PA-C, speaks with Adam Friedman, MD, FAAD, on innovative teledermatology initiatives in Washington, DC, addressing health care disparities and enhancing community access.
Explore innovative strategies for managing chronic hand eczema, focusing on personalized care, early treatment, and understanding complex subtypes for better outcomes.
Sonia Batra, MD, dispels common myths and shares expert tips on summer skin care for acne, emphasizing sun protection and tailored regimens.
Discover the latest advancements in vitiligo treatment and awareness as Dermatology Times highlights this year's progress during Vitiligo Awareness Month.
Explore insights on benzoyl peroxide and benzene risks in acne treatment from experts Renata Block, DMSc, MMS, PA-C, and John Barbieri, MD, MBA.
Sonia Batra, MD, shares effective summer acne solutions using lasers such as Aerolase Neo Elite and AviClear, ensuring tailored care for optimal skin health.
Arcutis Biotherapeutics' roflumilast cream 0.15% gains strong AAD endorsement for effective AD management in adults and children.
Abeona Therapeutics' VIITAL trial reveals promising results for RDEB treatment, showcasing significant wound healing and pain relief with Zevaskyn therapy.
Galderma launches clinical trials for nemolizumab, targeting systemic sclerosis and chronic pruritus of unknown origin, addressing critical patient needs.
Almirall showcased groundbreaking research on atopic dermatitis, psoriasis, and actinic keratosis at the 2025 ICD.
Nektar Therapeutics reveals positive results from the REZOLVE-AD study, showcasing rezpegaldesleukin's efficacy in treating moderate to severe AD.
Quoin Pharmaceuticals advances QRX003 for Netherton Syndrome, receiving FDA's RPD Designation and showing promising clinical results.
The FDA has accepted for review Allergan Aesthetics' sPMA for SKINVIVE by Juvéderm, seeking approval to treat neck lines.
Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.
Learn more about the in-depth topics covered in the June 2025 print issue of Dermatology Times.
Renata Block, DMSc, MMS, PA-C, interviews Andrew Baker, PA-C, MBA, to discuss his role as a sub-investigator in Castle Biosciences’ UTILISE study for cSCC.
At a recent Dermatology Times Case-Based Roundtable event, Andrew Baker, PA-C, MBA, explored the management of skin cancers with GEP testing through 4 complex cases.
Dermatology Times has compiled a list of dermatological meetings taking place during the month of July.
Incyte announces Ingenuity Awards and Innovators Program, empowering vitiligo advocates and enhancing patient care through innovative initiatives.
Discover how Robin Smith, MD, MBA, revolutionizes skin care with Exoceuticals, harnessing exosomes for advanced regenerative aesthetics and skin health solutions.
Medical trainees face heightened burnout, especially in dermatology, due to COVID-19's impact on emotional exhaustion and personal accomplishment.
This review of the latest dermatologic studies includes insights into effectiveness and cost-effectiveness of treatments for psoriasis, bubble hair deformity induced by bathroom heating lamp, and more.
Robin Smith, MD, MBA, champions exosome-powered skincare for long-lasting skin health and personalized regenerative aesthetics solutions for patients.
Anabela Cardoso, MD, reflects on specific data from the phase 3b ADmirable trial evaluating the safety and efficacy of lebrikizumab in patients with moderate to severe AD and pigmented skin.
E-learning enhances skin cancer detection by training professionals in OCT for accurate differentiation between basal cell carcinoma and non-BCC lesions.
A new paper highlights Alphyn Biologics' Zabalafin Hydrogel as a promising multi-target therapy for atopic dermatitis, addressing inflammation, itch, and bacterial complications.
Delgocitinib ointment shows promise as an effective, well-tolerated treatment for atopic dermatitis on the face and neck, enhancing patient satisfaction and reducing adverse effects.
Robin Smith, MD, MBA, discusses the future of regenerative aesthetics and her exosome-based skin care and hair care brand, Exoceuticals.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















